Skip to main content

Table 7 Results using the Merifluor assays as compared to established EBV status

From: Reliability of the Siemens Enzygnost and Novagnost Epstein–Barr Virus assays for routine laboratory diagnosis: agreement with clinical diagnosis and comparison with the Merifluor Epstein–Barr Virus immunofluorescence assay

 

Merifluor interpretation

Negative

Acute infection

Past infection

Indeterminate

% agreement with EBV status

EBV status

Negative (N = 39)

36

1

2

0

92.3

Acute infection (N = 15)

0

15

0

0

100

Past infection (N = 464)

1

5

455

3

98.1